Koers Percheron Therapeutics Limited OTC Markets
Aandelen
ATHJF
AU0000317281
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,012 USD | -84,00% |
|
-.--% | +20,00% |
Omzet 2024 * | 3,6 mln. 2,38 mln. 2,22 mln. | Omzet 2025 * | 5,3 mln. 3,51 mln. 3,27 mln. | Marktkapitalisatie | 82,94 mln. 54,86 mln. 51,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -13 mln. -8,6 mln. -8,03 mln. | Nettowinst (verlies) 2025 * | -31 mln. -20,5 mln. -19,15 mln. | EV/omzet 2024 * | 20,6 x |
Nettoliquiditeiten 2024 * | 8,92 mln. 5,9 mln. 5,51 mln. | Nettoliquiditeiten 2025 * | 17,43 mln. 11,53 mln. 10,77 mln. | EV/omzet 2025 * | 12,4 x |
K/w-verhouding 2024 * |
-5,87
x | K/w-verhouding 2025 * |
-2,34
x | Werknemers | 8 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,66% |
1 dag | -84,00% | ||
1 maand | +20,00% | ||
3 maanden | +20,00% | ||
6 maanden | -76,00% | ||
Lopend jaar | +20,00% |
![Extreem 0.012](/images/extremecours_fleche.png)
![Extreem 0.012](/images/extremecours_fleche.png)
![Extreem 0.01](/images/extremecours_fleche.png)
![Extreem 0.01](/images/extremecours_fleche.png)
![Extreem 0.01](/images/extremecours_fleche.png)
![Extreem 0.01](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Garner
CEO | Chief Executive Officer | - | 08-05-23 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 09-11-06 |
Anthony Filippis
COO | Chief Operating Officer | - | 01-11-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Phillip Hains
DFI | Director of Finance/CFO | 64 | 09-11-06 |
Ben Price
BRD | Director/Board Member | 68 | 04-10-21 |
James Garner
CEO | Chief Executive Officer | - | 08-05-23 |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,15% | 124 mld. | |
+18,02% | 112 mld. | |
+5,07% | 22,94 mld. | |
-12,75% | 22,22 mld. | |
-9,86% | 17,02 mld. | |
-14,97% | 16,88 mld. | |
-39,94% | 16,87 mld. | |
+2,80% | 13,63 mld. | |
+27,39% | 11,61 mld. |